Article

The Medical Innovation Threat

An invasive species has been introduced into the U.S. health innovation ecosystem, with a growing danger of permanent damage to the development of specialty drugs. The relentless assault on the price of Sovaldi is becoming a threat to the 30-year political balance that has energized the biomedical revolution.

Source: The Wall Street Journal

Read the full story: http://on.wsj.com/1vishjD

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Jeffrey Fitzgerald, JD
4 experts are featured in this series.
4 experts are featured in this series.
Dr Carrie Kitko
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo